Measles prevention: How the two-dose regimen works
About 90% of the U.S. population has gotten their two-dose regimen to protect against measles, mumps and rubella, but ...
MyChesCo on MSN1d
Wistar Institute Reveals Breakthrough in DNA-LNP Vaccine Technology
A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...